Abstract
Burning mouth syndrome (BMS) is characterized by burning sensations of the oral cavity in the absence of abnormalities of the oral mucosa. BMS predominantly affects middle-aged women. This condition has a multifactorial etiology. Multiple approaches to treatment have been described. This article examines BMS, its related factors, and treatment options.
MeSH terms
-
Age Factors
-
Aged
-
Amines / administration & dosage
-
Amines / therapeutic use
-
Analgesics / administration & dosage
-
Analgesics / therapeutic use
-
Anti-Anxiety Agents / administration & dosage
-
Anti-Anxiety Agents / therapeutic use
-
Antioxidants / administration & dosage
-
Antioxidants / therapeutic use
-
Burning Mouth Syndrome* / drug therapy
-
Burning Mouth Syndrome* / epidemiology
-
Burning Mouth Syndrome* / etiology
-
Burning Mouth Syndrome* / physiopathology
-
Burning Mouth Syndrome* / psychology
-
Burning Mouth Syndrome* / therapy
-
Clinical Trials as Topic
-
Cyclohexanecarboxylic Acids / administration & dosage
-
Cyclohexanecarboxylic Acids / therapeutic use
-
Diagnosis, Differential
-
Female
-
Gabapentin
-
Humans
-
Incidence
-
Male
-
Middle Aged
-
Prevalence
-
Sex Factors
-
Thioctic Acid / administration & dosage
-
Thioctic Acid / therapeutic use
-
Vitamin B Complex / administration & dosage
-
Vitamin B Complex / therapeutic use
-
gamma-Aminobutyric Acid / administration & dosage
-
gamma-Aminobutyric Acid / therapeutic use
Substances
-
Amines
-
Analgesics
-
Anti-Anxiety Agents
-
Antioxidants
-
Cyclohexanecarboxylic Acids
-
Vitamin B Complex
-
gamma-Aminobutyric Acid
-
Gabapentin
-
Thioctic Acid